- Report
- April 2025
- 110 Pages
Global
From €5322EUR$5,950USD£4,681GBP
- Report
- October 2025
- 181 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- October 2025
- 173 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Report
- June 2025
- 210 Pages
Global
From €4468EUR$4,995USD£3,930GBP
- Report
- July 2025
- 266 Pages
Global
From €3421EUR$3,825USD£3,009GBP
€4025EUR$4,500USD£3,541GBP
- Report
- May 2025
- 195 Pages
Global
From €5322EUR$5,950USD£4,681GBP
- Report
- July 2024
- 144 Pages
Global
From €2236EUR$2,500USD£1,967GBP
- Report
- May 2024
- 180 Pages
Global
From €4025EUR$4,500USD£3,541GBP
- Report
- February 2024
- 110 Pages
Global
From €4249EUR$4,750USD£3,737GBP
- Report
- March 2024
- 150 Pages
Global
From €3444EUR$3,850USD£3,029GBP
€4338EUR$4,850USD£3,816GBP
- Report
- October 2024
- 100 Pages
Global
From €3500EUR$4,192USD£3,186GBP
The Arbovirus Testing market is a subset of the larger Infectious Disease Testing market. It is focused on the detection of arboviruses, which are a group of viruses transmitted by arthropods such as mosquitoes, ticks, and sandflies. These viruses can cause a range of illnesses, including dengue, chikungunya, Zika, and yellow fever. Arbovirus Testing is used to diagnose and monitor these diseases, as well as to track the spread of arboviruses in a given population.
Arbovirus Testing is typically performed using molecular techniques such as PCR and RT-PCR, as well as serological methods such as ELISA and immunofluorescence. These tests are available from a variety of companies, including Abbott, Bio-Rad, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more